Previous Article | Next Article ![]()
Molecular and Cellular Biology, April 2000, p. 2556-2568, Vol. 20, No. 7
Department of Immunochemistry, German Cancer
Research Center, 69120 Heidelberg,1 and
Max Delbrück Center for Molecular Medicine, 13122 Berlin,3 Germany, and Department of
Medicine, University of Toronto, Toronto, Ontario M5S 1A8,
Canada2
Received 7 September 1999/Returned for modification 13 October
1999/Accepted 7 December 1999
The phosphorylation of I
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Mixed-Lineage Kinase 3 Delivers
CD3/CD28-Derived Signals into the I
B Kinase Complex
B by the multiprotein I
B kinase
complex (IKC) precedes the activation of transcription factor
NF-
B, a key regulator of the inflammatory response. Here we
identified the mixed-lineage group kinase 3 (MLK3) as an activator of
NF-
B. Expression of the wild-type form of this mitogen-activated
protein kinase kinase kinase (MAPKKK) induced nuclear immigration, DNA binding, and transcriptional activity of NF-
B. MLK3
directly phosphorylated and thus activated I
B kinase alpha (IKK
)
and IKK
, revealing its function as an I
B kinase kinase
(IKKK). MLK3 cooperated with the other two IKKKs, MEKK1 and
NF-
B-inducing kinase, in the induction of IKK activity. MLK3 bound
to components of the IKC in vivo. This protein-protein interaction was
dependent on the central leucine zipper region of MLK3. A
kinase-deficient version of MLK3 strongly impaired NF-
B-dependent
transcription induced by T-cell costimulation but not in response to
tumor necrosis factor alpha or interleukin-1. Accordingly, endogenous
MLK3 was phosphorylated and activated by T-cell costimulation but not
by treatment of cells with tumor necrosis factor alpha or
interleukin-1. A dominant negative version of MLK3 inhibited NF-
B-
and CD28RE/AP-dependent transcription elicited by the Rho family
GTPases Rac and Cdc42, thereby providing a novel link between these
GTPases and the IKC.
*
Corresponding author. Mailing address: Department of
Immunochemistry, German Cancer Research Center, Im Neuenheimer Feld
280, 69120 Heidelberg, Germany. Phone: 49-6221-423725. Fax:
49-6221-423746. E-mail: L.Schmitz{at}DKFZ-Heidelberg.de.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|